Antitumor and antiangiogenic activity of Schisandra chinensis polysaccharide in a renal cell carcinoma model

International Journal of Biological Macromolecules

Volumn 66, Issue , 2014, Pages 52-56

  Qu, Hai Ming ^a   Liu, Shi Jian ^a   Zhang, Chun Ying ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Antitumor and antiangiogenic activities; Polysaccharide; Renal cell carcinoma (RCC); Schisandra chinensis; Vascular endothelial growth factor (VEGF)

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; POLYSACCHARIDE; PROTEIN BAX; PROTEIN P53; SCHISANDRA CHINENSIS EXTRACT; VASCULOTROPIN; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER TISSUE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CARCINOMA; MALE; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PROTEIN EXPRESSION; PROTEIN SECRETION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CARCINOMA, RENAL CELL; CHEMISTRY; DRUG EFFECTS; KIDNEY NEOPLASMS; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC; NUDE MOUSE; SCHISANDRA; TUMOR CELL LINE;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIGENS, CD31; ANTIGENS, CD34; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; HUMANS; KIDNEY NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; POLYSACCHARIDES; SCHISANDRA; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84900353330     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2014.02.025     Document Type: Article

References (37)

1. Motzer R.J., Bander N.H., Nanus D.M. New England Journal of Medicine 1996, 335:865-875.
2. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., Thun M.J. CA: A Cancer Journal for Clinicians 2006, 56:106-130.
3. Amato R.J. Annals of Oncology 2005, 16:7-15.
4. Rini B.I. Clinical Cancer Research 2007, 13:1098-1106.
5. Weiss R.H., Lin P.Y. Kidney International 2006, 69:224-232.
6. Bellmunt J., Montagut C., Albiol S., Carles J., Maroto P., Orsola A. BJU International 2007, 99:274-280.
7. Lane B.R., Rini B.I., Novick A.C., Campbell S.C. Urology 2007, 69:3-10.
8. Wang X., Zhang L., O'Neill A., Bahamon B., Alsop D.C., Mier J.W., Goldberg S.N., Signoretti S., Atkins M.B., Wood C.G., Bhatt R.S. British Journal of Cancer 2013, 108:319-326.
9. Pirrotta M.T., Bernardeschi P., Fiorentini G. Current Medicinal Chemistry 2011, 18:1651-1657.
10. Flaherty K.T., Puzanov I. Biochemical Pharmacology 2010, 80:638-646.
11. Liu C.J., Zhang S.Q., Zhang J.S., Liang Q., Li D.S. Natural Product Research 2012, 26:2199-2203.
12. Wang Z.S., Chen H.X., Zhang W.J., Lan G.S., Zhang L.K. Journal of Medicinal Plant Research 2011, 5:1207-1216.
13. Yang L.Q., Chen R.H., Wu X.Y., Fan Q.Y., Zhao J.L. Food Science 2008, 29:392-394.
14. Chen Y., Tang J., Wang X., Sun F., Liang S. International Journal of Biological Macromolecules 2012, 50:844-848.
15. Zhao T., Mao G., Mao R., Zou Y., Zheng D., Feng W., Ren Y., Wang W., Zheng W., Song J., Chen Y., Yang L., Wu X. Food and Chemical Toxicology 2013, 55:609-616.
16. Xu C.L., Li Y.H., Dong M., Wu X., Wang X.C., Xiao Y.S. Carbohydrate Polymers 2012, 88:21-25.
17. Sheng Y., Liu Y., Huang X.D., Yuan G.X., Guan M. Journal of Medicinal Plants Research 2011, 5:5881-5888.
18. Gao X.X., Meng X.J., Li J.H., Tong H.B. Letters in Organic Chemistry 2009, 6:428-433.
19. Yan S., Yang L.Q., Zhao T., Zhao J.L., Zou Y.M. Journal of Jiangsu University Medicine 2009, 19:366-368.
20. Zhang D.Y., Wu J., Ye F., Xue L., Jiang S., Yi J., Zhang W., Wei H., Sung M., Wang W., Li X. Cancer Research 2003, 63:4037-4043.
21. Jung J.E., Lee H.G., Cho I.H., Chung D.H., Yoon S.H., Yang Y.M., Lee J.W., Choi S., Park J.W., Ye S.K., Chung M.H. FASEB Journal 2005, 19:1296-1298.
22. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Journal of Cell Biology 1992, 119:493-501.
23. Bae D.G., Gho Y.S., Yoon W.H., Chae C.B. Journal of Biological Chemistry 2000, 275:13588-13596.
24. Qi S.Y. Ai Zheng 2003, 22:320-323.
25. Lee S.J., Lee H.M., Ji S.T., Lee S.R., Mar W., Gho Y.S. Cancer Letter 2004, 208:89-94.
26. Pisacane A.M., Picciotto F., Risio M. Cellular Oncology 2007, 29:59-66.
27. Pusztaszeri M.P., Seelentag W., Bosman F.T. Journal of Histochemistry and Cytochemistry 2006, 54:385-395.
28. Han M.H., Lee W.S., Lu J.N., Kim G., Jung J.M., Ryu C.H., Kim G.Y., Hwang H.J., Kwon T.K., Choi Y.H. International Journal of Oncology 2012, 40:2090-2096.
29. Bourboulia D., Stetler-Stevenson W.G. Seminars in Cancer Biology 2010, 20:161-168.
30. Ak P., Levine A.J. FASEB Journal 2010, 24:3643-3652.
31. Sagar S.M., Yance D., Wong R.K. Current Oncology 2006, 13:99-107.
32. Bussolati B., Satolli M.A., Camussi G. Giornale Italiano Di Nefrologia 2008, 25:297-305.
33. Sharma S.G., Nanda S., Longo S. Recent Patents on Anti-Cancer Drug Discovery 2010, 5:77-83.
34. Rini B.I., Small E.J. Journal of Clinical Oncology 2005, 23:1028-1043.
35. Fukata S., Inoue K., Kamada M., Kawada C., Furihata M., Ohtsuki Y., Shuin T. Cancer 2005, 103:931-942.
36. Sciarra A., Gentile V., Salciccia S., Alfarone A., Di Silverio F. Reviews on Recent Clinical Trials 2008, 3:97-103.
37. Jacobsen J., Grankvist K., Rasmuson T., Bergh A., Landberg G., Ljungberg B. BJU International 2004, 93:297-302.